Skip to main content
920 search results for:

Mepolizumab 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 01-04-2024 | Mepolizumab | News

    Mepolizumab

    Hepatic cancer
  2. 01-04-2024 | Mepolizumab | News

    Mepolizumab

    Rheumatoid arthritis
  3. 01-03-2024 | Bronchiectasis | News

    Mepolizumab/omalizumab

    Lack of efficacy following off-label use
  4. 30-12-2023 | Mepolizumab | Letter

    Severe Idiopathic Hypereosinophilic Syndrome with Eosinophilic Cholecystitis in a Child Treated with Mepolizumab

  5. 01-02-2024 | Mepolizumab | News

    Mepolizumab

    Aggressive and invalidating atopic dermatitis
  6. 01-02-2024 | Mepolizumab | News

    Mepolizumab

    Lack of efficacy
  7. 01-02-2024 | Mepolizumab | News

    Mepolizumab/prednisolone

    Lumbar spinal epidural lipomatosis and lack of efficacy
  8. 01-02-2024 | Mepolizumab | News

    Mepolizumab

    Rheumatoid arthritis
  9. Open Access 01-12-2024 | Mepolizumab | OriginalPaper

    Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study

    Severe asthma represents less than 10% of the total asthma population but the care of such patients accounts for a disproportionate share of asthma care costs. In the United States (US), the annual direct cost per patient is up to US$9,175 for …

  10. Open Access 01-12-2024 | Mepolizumab | OriginalPaper

    When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report

    Severe asthma features a chronic airway inflammation mediated by many interleukins [ 1 , 2 ]. The advent of biologics directed toward T2 cytokines has changed the course of the disease and the quality of life of many severe asthmatics qualified as …

  11. 01-10-2023 | Mepolizumab | News

    Mepolizumab/mycophenolate/prednisolone

    Neural larva migrans: case report
  12. 01-09-2023 | Mepolizumab | News

    Mepolizumab

    Lack of efficacy following off label use: case report
  13. 01-08-2023 | Mepolizumab | News

    Mepolizumab/prednisolone

    Psoriasis vulgaris and lack of efficacy: case report
  14. 01-10-2023 | Mepolizumab | News

    Mepolizumab

    Palmoplantar psoriasis: case report
  15. Open Access 01-12-2023 | Vasculitis | OriginalPaper

    Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis

    Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immunological condition characterized by allergic granulomatosis and small- and medium-vessel necrotizing vasculitis associated with peripheral blood eosinophilia and tissue …

  16. 01-05-2023 | Herpes Virus | News

    Mepolizumab/prednisone

    Diabetes-mellitus and herpes-zoster: case report
  17. Open Access 01-12-2023 | Omalizumab | OriginalPaper

    Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein–protein interaction analyses

    With a growing number of monoclonal antibodies (‘biologics’) approved for the treatment of moderate to severe asthma, patients and their providers are having to make an increasing number of therapeutic decisions on the optimal therapy for patients …

  18. Open Access 01-12-2023 | Mepolizumab | OriginalPaper

    Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan

    Eosinophilic granulomatosis with polyangiitis (EGPA) was defined as a type of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis at the 2012 Revised International Chapel Hill Consensus Conference. Histologically, EGPA is …

  19. 01-11-2022 | Mepolizumab | News

    Mepolizumab

    Treatment ineffective: case report
  20. 01-07-2022 | Salbutamol | News

    Mepolizumab/prednisone/theophylline

    Lack of efficacy and rebound effect in the form of tropical pulmonary eosinophilia recrudescence: case report

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.